NIH Research Matters

Middle-aged woman holds the back of her left hand to her forehead.
News

Antiviral drug did not improve Long COVID symptoms

A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
X-ray of the human lung.
News

tRNA treatment may help restore cystic fibrosis proteins

Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
Medical illustration of Clostridioides difficile bacteria
News

Bacterial infection may alter developing gut

C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.

 

Displaying 239 - 245 of 912

Preventing severe allergic reactions with nanoparticles

Researchers created nanoparticles that could deactivate immune cells and prevent severe allergic reactions in mice.

Machine learning identifies federally protected waters

Researchers used machine learning to estimate which waters are protected by the Clean Water Act, which provides the basis for federal regulation of water quality, including water for drinking.

Comparing side effects after prostate cancer treatment

Men with cancer confined to the prostate experienced different long-term side effects depending on the type of treatment received.
Research in Context

Diagnosing dementia

This special Research in Context feature explores approaches to the diagnosis of Alzheimer’s and other dementias and the development of strategies to try to prevent their progression.

People taking semaglutide had lower risk of suicidal thoughts

Semaglutide was associated with a lower risk of suicidal thoughts than other anti-obesity and anti-diabetes drugs.

Plastic particles in bottled water

Researchers developed an imaging technique that detected thousands of tiny bits of plastic in common single-use bottles of water.

Infections and falls increased in private equity-owned hospitals

After hospitals were purchased by private equity firms, patients had a substantial increase in infections, falls, and other adverse events.